Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Nov;74(9):1349–1353. doi: 10.1038/bjc.1996.548

Metabolism and pharmacokinetics of the anti-tumour agent 2,3,5-trimethyl-6-(3-pyridylmethyl)1,4-benzoquinone (CV-6504).

H J Hussey 1, M J Tisdale 1
PMCID: PMC2074783  PMID: 8912528

Abstract

2,3,5-Trimethyl-6-(3-pyridylmethyl)1,4-benzoquinone (CV-6504) is an effective inhibitor of the growth of established murine adenocarcinomas (MACs) and is shortly to enter clinical investigation. When administered to mice bearing the MAC16 tumour, CV-6504 rapidly disappeared from the plasma and tissues and there was an accumulation of the sulphate and glucuronide metabolites. After 24 h, the concentration of free CV-6504 in the tumour (3.3 microM) was higher than that in the liver (0.24 microM) and equal to the IC50 value for the inhibition of the growth of MAC16 cells in vitro (3 microM). The concentration of glucuronide and sulphate metabolites in both tumour and liver decreased with time. Both the MAC16 tumour and the liver possessed similar beta-glucuronidase activity, which could account for the accumulation of free CV-6504. Although the sulphate and glucuronide conjugates of CV-6504 were ineffective inhibitors of the growth of MAC13 cells in vitro at concentrations up to 100 microM, in vivo at a concentration of 50 mg kg-1 day-1 the conjugates produced a similar anti-tumour effect to CV-6504 at a concentration of 5 mg kg-1 day-1. The MAC13 tumour possessed both beta-glucuronidase and sulphatase activity capable of converting the sulphate and glucuronide conjugates to free CV-6504. Using MAC13 cells ex vivo, CV-6504 inhibited conversion of arachidonic acid to 5-, 12- and 15-hydroxyeicosatetraenoic acids (HETE). The percentage reduction in formation of 12- and 15-HETE exceeded that of 5-HETE. Inhibition of HETE formation may be responsible for the anti-tumour activity of CV-6504.

Full text

PDF
1349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bandyopadhyay G. K., Imagawa W., Wallace D. R., Nandi S. Proliferative effects of insulin and epidermal growth factor on mouse mammary epithelial cells in primary culture. Enhancement by hydroxyeicosatetraenoic acids and synergism with prostaglandin E2. J Biol Chem. 1988 Jun 5;263(16):7567–7573. [PubMed] [Google Scholar]
  2. Buckman D. K., Hubbard N. E., Erickson K. L. Eicosanoids and linoleate-enhanced growth of mouse mammary tumor cells. Prostaglandins Leukot Essent Fatty Acids. 1991 Nov;44(3):177–184. doi: 10.1016/0952-3278(91)90053-8. [DOI] [PubMed] [Google Scholar]
  3. Connors T. A., Whisson M. E. Cure of mice bearing advanced plasma cell tumours with aniline mustard: the relationship between glucuronidase activity and tumour sensitivity. Nature. 1966 May 21;210(5038):866–867. doi: 10.1038/210866b0. [DOI] [PubMed] [Google Scholar]
  4. Glasgow W. C., Eling T. E. Epidermal growth factor stimulates linoleic acid metabolism in BALB/c 3T3 fibroblasts. Mol Pharmacol. 1990 Oct;38(4):503–510. [PubMed] [Google Scholar]
  5. Hudson E. A., Beck S. A., Tisdale M. J. Kinetics of the inhibition of tumour growth in mice by eicosapentaenoic acid-reversal by linoleic acid. Biochem Pharmacol. 1993 Jun 9;45(11):2189–2194. doi: 10.1016/0006-2952(93)90188-3. [DOI] [PubMed] [Google Scholar]
  6. Hussey H. J., Bibby M. C., Tisdale M. J. Novel anti-tumour activity of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4- benzoquinone (CV-6504) against established murine adenocarcinomas (MAC). Br J Cancer. 1996 May;73(10):1187–1192. doi: 10.1038/bjc.1996.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Liu B., Maher R. J., Hannun Y. A., Porter A. T., Honn K. V. 12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC alpha. J Natl Cancer Inst. 1994 Aug 3;86(15):1145–1151. doi: 10.1093/jnci/86.15.1145. [DOI] [PubMed] [Google Scholar]
  8. Liu B., Marnett L. J., Chaudhary A., Ji C., Blair I. A., Johnson C. R., Diglio C. A., Honn K. V. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential. Lab Invest. 1994 Mar;70(3):314–323. [PubMed] [Google Scholar]
  9. Lysz T. W., Arora J. K., Lin C., Zelenka P. S. 12(S)-hydroxyeicosatetraenoic acid regulates DNA synthesis and protooncogene expression induced by epidermal growth factor and insulin in rat lens epithelium. Cell Growth Differ. 1994 Oct;5(10):1069–1076. [PubMed] [Google Scholar]
  10. Ohkawa S., Terao S., Terashita Z., Shibouta Y., Nishikawa K. Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives. J Med Chem. 1991 Jan;34(1):267–276. doi: 10.1021/jm00105a042. [DOI] [PubMed] [Google Scholar]
  11. Ohkawa S., Terao T., Murakami M., Matsumoto T., Goto G. Reduction of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone by PB-3c cells and biological activity of its hydroquinone. Chem Pharm Bull (Tokyo) 1991 Apr;39(4):917–921. doi: 10.1248/cpb.39.917. [DOI] [PubMed] [Google Scholar]
  12. Rao G. N., Alexander R. W., Runge M. S. Linoleic acid and its metabolites, hydroperoxyoctadecadienoic acids, stimulate c-Fos, c-Jun, and c-Myc mRNA expression, mitogen-activated protein kinase activation, and growth in rat aortic smooth muscle cells. J Clin Invest. 1995 Aug;96(2):842–847. doi: 10.1172/JCI118130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rose D. P., Connolly J. M., Rayburn J., Coleman M. Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J Natl Cancer Inst. 1995 Apr 19;87(8):587–592. doi: 10.1093/jnci/87.8.587. [DOI] [PubMed] [Google Scholar]
  14. Setty B. N., Graeber J. E., Stuart M. J. The mitogenic effect of 15- and 12-hydroxyeicosatetraenoic acid on endothelial cells may be mediated via diacylglycerol kinase inhibition. J Biol Chem. 1987 Dec 25;262(36):17613–17622. [PubMed] [Google Scholar]
  15. Simon A., Najid A., Chulia A. J., Delage C., Rigaud M. Inhibition of lipoxygenase activity and HL60 leukemic cell proliferation by ursolic acid isolated from heather flowers (Calluna vulgaris). Biochim Biophys Acta. 1992 Apr 8;1125(1):68–72. doi: 10.1016/0005-2760(92)90157-q. [DOI] [PubMed] [Google Scholar]
  16. Tang D. G., Renaud C., Stojakovic S., Diglio C. A., Porter A., Honn K. V. 12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. Biochem Biophys Res Commun. 1995 Jun 15;211(2):462–468. doi: 10.1006/bbrc.1995.1836. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES